These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 10406804)

  • 21. Wilms' tumor gene WT1-shRNA as a potent apoptosis-inducing agent for solid tumors.
    Tatsumi N; Oji Y; Tsuji N; Tsuda A; Higashio M; Aoyagi S; Fukuda I; Ito K; Nakamura J; Takashima S; Kitamura Y; Miyai S; Jomgeow T; Li Z; Shirakata T; Nishida S; Tsuboi A; Oka Y; Sugiyama H
    Int J Oncol; 2008 Mar; 32(3):701-11. PubMed ID: 18292948
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of insulin-like growth factor I receptor promoter activity by wild-type and mutant versions of the WT1 tumor suppressor.
    Tajinda K; Carroll J; Roberts CT
    Endocrinology; 1999 Oct; 140(10):4713-24. PubMed ID: 10499530
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of Bcl-2 in Wilms' tumor and oncogenic potential of Bcl-X(L) in rare tumor cases.
    Re GG; Hazen-Martin DJ; El Bahtimi R; Brownlee NA; Willingham MC; Garvin AJ
    Int J Cancer; 1999 Apr; 84(2):192-200. PubMed ID: 10096254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Wilms' tumor suppressor, WT1, inhibits 12-O-tetradecanoylphorbol-13-acetate activation of the multidrug resistance-1 promoter.
    McCoy C; McGee SB; Cornwell MM
    Cell Growth Differ; 1999 Jun; 10(6):377-86. PubMed ID: 10392899
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Wilms tumor and the WT1 gene.
    Lee SB; Haber DA
    Exp Cell Res; 2001 Mar; 264(1):74-99. PubMed ID: 11237525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Wilms' tumor 1-KTS isoforms induce p53-independent apoptosis that can be partially rescued by expression of the epidermal growth factor receptor or the insulin receptor.
    Menke AL; Shvarts A; Riteco N; van Ham RC; van der Eb AJ; Jochemsen AG
    Cancer Res; 1997 Apr; 57(7):1353-63. PubMed ID: 9102224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxygen-regulated expression of the Wilms' tumor suppressor Wt1 involves hypoxia-inducible factor-1 (HIF-1).
    Wagner KD; Wagner N; Wellmann S; Schley G; Bondke A; Theres H; Scholz H
    FASEB J; 2003 Jul; 17(10):1364-6. PubMed ID: 12738801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CTNNB1 mutations and overexpression of Wnt/beta-catenin target genes in WT1-mutant Wilms' tumors.
    Li CM; Kim CE; Margolin AA; Guo M; Zhu J; Mason JM; Hensle TW; Murty VV; Grundy PE; Fearon ER; D'Agati V; Licht JD; Tycko B
    Am J Pathol; 2004 Dec; 165(6):1943-53. PubMed ID: 15579438
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of WT1 target gene expression in stably transfected cell lines.
    Thäte C; Englert C; Gessler M
    Oncogene; 1998 Sep; 17(10):1287-94. PubMed ID: 9771972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of WT1 protein in fetal kidneys and Wilms tumors.
    Grubb GR; Yun K; Williams BR; Eccles MR; Reeve AE
    Lab Invest; 1994 Oct; 71(4):472-9. PubMed ID: 7967503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Wilms' tumor protein (-KTS) modulates renin gene transcription.
    Steege A; Fähling M; Paliege A; Bondke A; Kirschner KM; Martinka P; Kaps C; Patzak A; Persson PB; Thiele BJ; Scholz H; Mrowka R
    Kidney Int; 2008 Aug; 74(4):458-66. PubMed ID: 18496514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Midkine as a novel target gene for the Wilms' tumor suppressor gene (WT1).
    Adachi Y; Matsubara S; Pedraza C; Ozawa M; Tsutsui J; Takamatsu H; Noguchi H; Akiyama T; Muramatsu T
    Oncogene; 1996 Nov; 13(10):2197-203. PubMed ID: 8950987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transcriptional repression of human insulin-like growth factor-II P4 promoter by Wilms' tumor suppressor WT1.
    Lee YI; Kim SJ
    DNA Cell Biol; 1996 Feb; 15(2):99-104. PubMed ID: 8634146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Wilms' tumor suppressor WT1: approaches to gene function.
    Menke A; McInnes L; Hastie ND; Schedl A
    Kidney Int; 1998 Jun; 53(6):1512-8. PubMed ID: 9607183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human platelet-derived growth factor A chain is transcriptionally repressed by the Wilms tumor suppressor WT1.
    Gashler AL; Bonthron DT; Madden SL; Rauscher FJ; Collins T; Sukhatme VP
    Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10984-8. PubMed ID: 1332065
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overlapping RNA and DNA binding domains of the wt1 tumor suppressor gene product.
    Bardeesy N; Pelletier J
    Nucleic Acids Res; 1998 Apr; 26(7):1784-92. PubMed ID: 9512553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Upregulation of c-MYC in WT1-mutant tumors: assessment of WT1 putative transcriptional targets using cDNA microarray expression profiling of genetically defined Wilms' tumors.
    Udtha M; Lee SJ; Alam R; Coombes K; Huff V
    Oncogene; 2003 Jun; 22(24):3821-6. PubMed ID: 12802290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. WT1 splicing alterations in Wilms' tumors.
    Baudry D; Hamelin M; Cabanis MO; Fournet JC; Tournade MF; Sarnacki S; Junien C; Jeanpierre C
    Clin Cancer Res; 2000 Oct; 6(10):3957-65. PubMed ID: 11051244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Products of alternatively spliced transcripts of the Wilms' tumor suppressor gene, wt1, have altered DNA binding specificity and regulate transcription in different ways.
    Wang ZY; Qiu QQ; Huang J; Gurrieri M; Deuel TF
    Oncogene; 1995 Feb; 10(3):415-22. PubMed ID: 7845666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Wilms' tumor suppressor Wt1 activates transcription of the erythropoietin receptor in hematopoietic progenitor cells.
    Kirschner KM; Hagen P; Hussels CS; Ballmaier M; Scholz H; Dame C
    FASEB J; 2008 Aug; 22(8):2690-701. PubMed ID: 18424770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.